ArchiMed SAS acquired Suan Farma, S.A.U from ICG Europe Fund VI managed by Intermediate Capital Group plc (LSE:ICP) and other shareholders on September 21, 2021. Madrid office corporate partner José Antonio Sánchez-Dafos and London partner Farah O'Brien, On behalf of the Spanish office, Finance partner Fernando Colomina, counsel Luis Sánchez and Juan Rodríguez in the Tax area, of The Latham & Watkins acted as Legal advisors to the ArchiMed. The transaction has also involved several of the firm's offices, including an international Regulatory and Sanctions team made up of Washington D.C. lawyers Les Carnegie and Ehson Kashmir. Les Carnegie and Ehson Kashfipour, Kiera Murphy in San Diego, and Paul Davies, Charles Claypoole, Michael Green, Amaryllis Bernitsa and Thomas Lane in London. Íñigo del Val and Regina Mozo de Rosales of Allen & Overy acted as legal advisors to the Intermediate Capital Group. Ernst & Young Global Limited provided financial due diligence to ICG Europe Fund VI. PWC Corporate Finance acted as a financial advisor, PwC Transaction Services, and Pwc Strategy& (France) S.A.S., PwC Société d'Avocats, provided the due diligence to ArchiMed SAS. Mavens acted as legal advisor, The Boston Consulting Group, Inc. and Ernst & Young Global Limited acted as due diligence provider and Rothschild & Co SCA (ENXTPA:ROTH) acted as financial advisor to Intermediate Capital Group plc.

ArchiMed SAS completed the acquisition of Suan Farma, S.A.U from ICG Europe Fund VI managed by Intermediate Capital Group plc (LSE:ICP) and other shareholders on September 21, 2021. Teresa Zueco, Diego Ramos and Adolfo Navarrete of DLA Piper Rudnick Gray Cary Spain S.L acted as legal advisors to ArchiMed.